Penile carcinoma: lessons learned from vulvar carcinoma

Area of Science:

• Oncology
• Gynecologic Oncology
• Urologic Oncology

Background:

• Penile carcinoma management lacks robust clinical data due to its rarity.
• Vulvar carcinoma research provides a stronger evidence base with parallels to penile carcinoma.
• Existing penile carcinoma treatment guidelines are often based on limited data.

Purpose of the Study:

• To review vulvar carcinoma literature for potential improvements in penile carcinoma care.
• To identify established diagnostic and treatment strategies in vulvar cancer applicable to penile cancer.
• To guide future research and clinical trials for penile carcinoma.

Main Methods:

• A comprehensive literature review of vulvar carcinoma was conducted.
• Direct comparisons were made between vulvar and penile carcinoma literature.
• Evidence from vulvar cancer studies was assessed for extrapolation to penile cancer.

Main Results:

• Human papillomavirus (HPV) role is understudied in penile carcinoma compared to vulvar carcinoma.
• Vulvar carcinoma staging (size, depth of invasion) is more refined than penile carcinoma TNM staging.
• Inguinal lymph node management in vulvar cancer, including sentinel node biopsy, is more advanced.
• Adjuvant and neoadjuvant therapies (radiation, chemotherapy) are better established for vulvar carcinoma.

Conclusions:

• Evidence from vulvar carcinoma studies can inform penile carcinoma clinical trials.
• Extrapolation of vulvar cancer data can enhance diagnostic and treatment strategies for penile carcinoma.
• Further research is needed to validate these findings in penile carcinoma patients.